Altimmune ALT Balance Sheet Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $43.8M+18.5% | $36.97M-72.6% | $135.16M+21.6% | $111.13M-41.6% | ||
| $229.7M+142% | $94.97M+51.5% | $62.7M-15.0% | $73.78M— | ||
| $42K0.0% | $42K+2.4% | $41K+20.6% | $34K0.0% | ||
| $1.22M+124% | $544K-51.0% | $1.11M+542% | $173K-59.7% | ||
| $2.96M+34.2% | $2.2M-68.1% | $6.92M+29.1% | $5.36M-32.6% | ||
| $278.19M+103% | $137.25M-34.5% | $209.63M+8.7% | $192.81M-5.5% | ||
| $312K-24.5% | $413K-36.6% | $651K-39.8% | $1.08M-25.3% | ||
| —— | —— | —— | —— | ||
| $1.43M-13.1% | $1.64M+352% | $363K-41.0% | $615K-29.5% | ||
| $279.93M+101% | $139.31M-33.9% | $210.64M+1.8% | $206.93M-5.5% | ||
| $2.72M+1,188% | $211K-89.8% | $2.07M-56.9% | $4.8M+136% | ||
| $256K-8.2% | $279K-43.8% | $496K+9.7% | $452K+10.0% | ||
| $15M+43.3% | $10.47M-13.8% | $12.14M-28.8% | $17.05M-6.7% | ||
| $34.29M— | —— | —— | $4.58M+215% | ||
| $5.75M+7.9% | $5.33M— | —— | —— | ||
| $55.04M+248% | $15.8M-4.5% | $16.54M-23.5% | $21.64M+9.7% | ||
| $11K+57.1% | $7K0.0% | $7K+40.0% | $5K+25.0% | ||
| $879.29M+27.5% | $689.86M+3.7% | $665.43M+17.1% | $568.4M+14.3% | ||
| -$649.48M-15.7% | -$561.39M-20.4% | -$466.33M-23.4% | -$377.88M-28.9% | ||
| -$4.93M+0.9% | -$4.97M+0.6% | -$5M+4.3% | -$5.23M-3.7% | ||
| $224.89M+82.1% | $123.51M-36.4% | $194.1M+4.8% | $185.29M-7.0% | ||
| $279.93M+101% | $139.31M-33.9% | $210.64M+1.8% | $206.93M-5.5% | ||
| $518K-79.9% | $2.57M-31.2% | $3.74M+58.0% | $2.37M-56.2% | ||
| $1.43M-13.1% | $1.64M+352% | $363K-41.0% | $615K-29.5% | ||
| $1.43M-13.1% | $1.64M+352% | $363K-41.0% | $615K-29.5% | ||
| $229.7M+142% | $94.97M+51.5% | $62.7M-15.0% | $73.78M— | ||
| $1.43M-13.1% | $1.64M+352% | $363K-41.0% | $615K-29.5% | ||
| $12.28M+19.7% | $10.26M+1.8% | $10.07M-17.8% | $12.25M+20.7% | ||
| $35.69M+2,023% | $1.68M+151% | $671K-88.2% | $5.71M+90.9% | ||
| $11K+57.1% | $7K0.0% | $7K+40.0% | $5K+25.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Altimmune's total assets?
- Altimmune (ALT) holds $335.6M in total assets, up 113.4% year over year.
- How much debt does Altimmune have?
- Altimmune carries $34.8M in total debt against $284.0M of shareholders' equity, a debt-to-equity ratio of 0.12.
- How much cash does Altimmune have?
- Altimmune holds $97.6M in cash and equivalents.
- Can Altimmune cover its short-term obligations?
- Its current ratio is 29.56 — current assets exceed current liabilities.
- Where does Altimmune's balance sheet data come from?
- Every line is extracted from Altimmune's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
